Removing Neumann is a difficult decision for Son, who has long believed in WeWork and Neumann's vision to quickly expand the company.Technologyread more
The Kingdom and oil and gas industry have been slow to shore up defenses, raising red flags about the possibility of longer term fall-out in the region.Technologyread more
Datadog went public on Thursday and instantly hit a $10 billion valuation, becoming the fourth cloud software debut to reach that level this year.Technologyread more
There are challenges with Iran, North Korea, the Afghan Taliban, Israel and the Palestinians — not to mention a number of trade pacts.Politicsread more
Blackstone Executive Vice Chairman Tony James says he's less optimistic now than before that the U.S.-China trade war could be resolved, but even a smaller deal could help...World Economyread more
In his new memoir, "The Ride of a Lifetime," Iger explains why he decided against the deal to buy Twitter.Technologyread more
In perhaps Buffett's first televised profile, he explained a method of investing that prioritizes bargains and makes use of an occasional baseball analogy.Marketsread more
The massive market transformation this month that some on Wall Street called a "once in a decade opportunity" might have just been a one-off technical move because of taxes.Marketsread more
A 58% majority of registered voters express unease about voting for Trump, but slightly more say the same about Joe Biden and Bernie Sanders, while Elizabeth Warren fares only...Politicsread more
A temporary airspace closure forced flights coming into Dubai from Australia, Singapore and India to be diverted to nearby airports.Airlinesread more
Schiff had previously shied away from calling for impeachment, but his comments on CNN's "State of the Union" indicate his stance has shifted.Politicsread more
The presidential hopefuls aren't the only ones eyeing health-care issues for 2020. Large employers are putting together benefit plans for next year, and they are expecting the rise in employee health costs to hit a four-year high, in part, due to rising drug prices.
Private employer medical costs are projected to increase by an average of 6% next year, after averaging about 5.5% annually over the last three years, according to PwC Health Research Institute's annual Medical Cost Trend survey of more than 500 of the nation's largest employers.
The jump in spending is being attributed to expensive specialty drugs that weren't available a few years ago. Researchers say spending on specialty medications to treat cancer and other complex diseases now makes up more than 40% of overall employer drug spending.
"The portion of the pie that goes to specialty drugs is growing and has grown substantially, so that's one big reason why we think there'll be a big uptick in drug spending over the next decade," said Ben Isgur, who leads PwC's Health Research Institute.
Drug spending is expected to grow more than 3% next year, and that growth rate is expected to double by 2023. While still well below the 13% spike in costs following the introduction of new hepatitis C drugs in 2014, the trend has employers looking to get ahead of increases.
PwC says more large employers will likely look to boost the use of biosimilars — lower cost versions of biologic drugs, which are complex medications that use parts of tissues, genes and other living organisms to create more targeted treatments.
It will take more coaxing of physicians and patients to use them more, says Isgur. PwC's own research found nearly 3 in 4 doctors remain leery of recommending biosimilars, in part because they were not significantly cheaper.
"If we go back a couple of decades, we were having the same conversation regarding generic and branded drugs. Of course, now … 80% of prescriptions are generic," he said.
Employers are also taking a more hands-on approach to control the costs of medical care. Plans with high deductibles and digital tools to shop for cheaper care were intended to make workers better health-care consumers, but now more companies are trying to take the guess work out of finding cost-effective care.
"What we're seeing is employers saying, 'the way it's working now is not great for my employees and so I need to get more active' and more controlling working with the provider system," said Isgur.
More employers are contracting directly with health systems on hospital costs for high-priced care like surgery. They're also being more hands-on about preventive care.
Tech firms like Amazon, Apple and Tesla opened on-site clinics in 2018. PwC says more employers will likely look to contract with local health systems, providers like One Medical and potentially CVS Health's new health hubs to provide off-site primary care and help employees manage chronic conditions like diabetes.
Helping workers get healthier pays off in the long run. Medical costs for workers with chronic conditions like diabetes or heart disease can run more than three times that of healthy workers, according to PwC.
But achieving those savings doesn't come cheap. PwC says more employers may look to offer more financial incentives to engage workers to actually manage their chronic conditions. For at-risk workers, that could mean lower or zero co-pays on diabetes and heart disease medications, and other incentives for managing their health.